Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

DIA Global Center

11 sep 2017 8:15 a.m. - 12 sep 2017 3:30 p.m.

21 Dupont Circle NW, Suite 300, Washington, DC 20036

Navigating Chemistry, Manufacturing, and Controls Through the Drug Development Process

Facultad

Albert S. Yehaskel, MBA

Albert S. Yehaskel, MBA

President and CEO, Refuah Global Pharmaceutical Development, Inc., United States

Albert Yehaskel is an experienced and accomplished pharmaceutical professional with a distinguished record of achievement and success in the management of regulatory affairs. He has been in the pharmaceutical industry for over 40 years. He has an MSc in Organic Chemistry and an MBA in Economics and Finance. Albert began his career in medicinal research, working for Schering-Plough Corporation, in the area of trisaccharide antibiotic research: Gentamicin, Sisomicin and semi-synthetic antibiotics, replacing a natural sugar with a synthetic moiety to create new synthetic antibiotics. He subsequently gained additional research experience with CNS drugs and polypeptides.

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.